Human Igg1 Monoclonal Antibody Against Human Il-1 Beta And Human Il-18

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

6 Countries

Phase II

Phase II: 3

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Autoinflammation with infantile enterocolitis 1 Still's disease 1 Immune-mediated enterocolitis 1

Sponsors using this IMP

Novartis Pharma AG 3

All trials

3 total

An open-label phase II trial to evaluate the clinical efficacy, safety and tolerability of MAS825 in pediatric and adult participants with S… Recruiting

2024-520208-25-00 Phase II 5 countries Novartis Pharma AG
Study to evaluate the efficacy and safety of MAS825 in patients with autoinflammatory diseases. Ended

2023-504419-34-00 Phase II 4 countries Novartis Pharma AG
A randomized, placebo-controlled, parallel-group, investigator- and participant-blinded Phase 2a study to investigate the efficacy, safety, … Ended

2023-506741-34-00 Phase II 1 country Novartis Pharma AG

Showing 1–3 of 3 trials

← All drugs A–Z